Mehreen Datoo

Infectious Diseases/Microbiology Clinical Lecturer @UniofOxford @JennerInstitute. Views my own.

[Mehreen Datoo @DrMSDatoo]

The phase II results of our malaria vaccine demonstrating 77% efficacy can now be found in the Lancet @HalTinto @ProfKatieEwer https://t.co/xO2wxzvXFO

[University of Oxford @UniofOxford]

NEW: Oxford R21 malaria vaccine receives @WHO recommendation paving the way for global roll-out.

The vaccine developed by Oxford & @SerumInstIndia demonstrates a high efficacy.

The jab could reduce over half a million malaria-related deaths annually.

#OxfordVaccine

[University of Oxford @UniofOxford]

Our malaria vaccine - co-developed with @SerumInstIndia - can be manufactured at mass scale and modest cost, enabling as many as 100s of millions of doses to be supplied to African countries which are suffering a significant malaria burden.
#OxfordVaccine
https://t.co/f8q9uP0KKM

[University of Oxford @UniofOxford]

'The goal is to completely eradicate malaria.'

The researchers behind Oxford's malaria vaccine share why the jab could be a potential game-changer in Africa.

#OxfordVaccine

[Mehreen Datoo @DrMSDatoo]

Thank you to @IDJClub and @Boghuma for choosing to review our paper this week

[ID Journal Club @IDJClub]

Once again here is the visual abstract highlighting the salient points of this study in case you missed it at the start. Hope you enjoyed the @IDJClub first tropical medicine paper😊. It was my pleasure moderating tonight's lively discussions!
#IDJClub

[Mehreen Datoo @DrMSDatoo]

Our promising phase III R21/MM malaria vaccine starts in Mali

[University of Oxford @UniofOxford]

ℹ️ | Malaria vaccine update

First vaccinations have now begun in Mali in a phase III trial of a malaria vaccine developed at @UniofOxford.

It is hoped that this phase III trial will help lead to licensure of the vaccine by 2023.

More info ⬇️

[University of Oxford @UniofOxford]

NEW: Oxford researchers find malaria vaccine is highly effective:

• Vaccine efficacy of 77% in African children

• Vaccine, trialled in 450 children, shows favourable safety profile and was well-tolerated

More info ⬇️
https://t.co/vOvEuICo2Q

[Jenner Institute @JennerInstitute]

Today is #WorldMalariaDay. We are excited to be starting large-scale safety and efficacy trials across four African countries, in 4,800 children aged 5-36 months.

[Pedro L. Alonso @PAlonsoMalaria]

In 2017 @WHO launched the E-2020 initiative to support 21 countries in their efforts to get to zero #malaria cases by 2020.

Today we report on the progress and the exciting addition of a new group of 25 countries w/the potential to #EndMalaria by 2025.
📢https://t.co/iK4MuV2vNZ

[Katharine Collins @Kat_a_Collins]

Amazing results from a Phase 2 study of #R21 the #malaria #vaccine I made in the lab 8 years ago! 77% efficacy! So proud to have played a part. Huge congratulations to the whole team who made this happen @JennerInstitute @HalTinto @DrMSDatoo @SerumInstIndia @ProfKatieEwer

[Mehreen Datoo @DrMSDatoo]

Our exciting malaria vaccine results from Burkina Faso @HalTinto @ProfKatieEwer @Kat_a_Collins @JennerInstitute @SerumInstIndia @Novavax https://t.co/T3n4p8GTj2